ALA — Arovella Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- AU$109.16m
- AU$104.39m
- AU$0.44m
Annual balance sheet for Arovella Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.31 | 0.977 | 6.72 | 6.07 | 5.18 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.12 | 0.869 | 0.534 | 0.036 | 0.01 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.6 | 2.03 | 7.34 | 6.59 | 5.42 |
| Net Property, Plant And Equipment | 0.367 | 0.422 | 0.433 | 0.371 | 0.05 |
| Net Intangible Assets | |||||
| Total Assets | 16.3 | 6.71 | 10.7 | 9.21 | 5.47 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.35 | 2.02 | 1.69 | 1.51 | 1.68 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.28 | 2.57 | 1.71 | 1.6 | 1.69 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 14 | 4.14 | 8.98 | 7.62 | 3.78 |
| Total Liabilities & Shareholders' Equity | 16.3 | 6.71 | 10.7 | 9.21 | 5.47 |
| Total Common Shares Outstanding |